investigating misconduct and implementing remedies. As was previously said, the U.S. government policy on research misconduct and agency rules that follow it lay the primary burden for investigating claims of research misconduct on research organizations (HHS, 2005; NSF, 2002; OSTP, 2000).
Institutions should have a process in place to look into allegations of wrongdoing, disclose results to the NIH Office of Research Integrity (ORI), and shield both the accuser and the whistleblower until a decision is reached.
Research misconduct is the fabrication, falsification, or plagiarism of information when proposing, conducting, reviewing, or reporting research. (A) Fabrication is the act of creating up information and then documenting or disclosing it.
Research misconduct is described as fabrication, falsification, or plagiarism in the design, conduct, or review of a research study, as well as in the publication of the study's findings. Fabrification is the act of inventing information and documenting or reporting it.
Learn more about Research misconduct
brainly.com/question/13186234
#SPJ9
Given what we know about uterine changes during ovulation, we can confirm that the most suggestive option to determine if the client is ovulating is the change in the cervical mucus.
During ovulation, many changes occur in the uterine in preparation for the possible fertilization of the egg and its subsequent implantations into the uterine wall. Of these changes, the most useful is the change to the mucus of the endometrium.
The endometrium is the outermost layer of the uterine wall, therefore, it is where the glands that will secrete hormones are located. During ovulation, the changes to this layer are clear and can provide unmistakable evidence of ovulation. One such evidence is the secretion of hormones specific to this stage in the menstrual cycle.
<em><u>This was answered based on the complete question found online which states:</u></em>
<em>A client is being prepared for artificial insemination. Which finding is the most suggestive to determine if the client is ovulating?
</em>
<em>
</em>
<em>A) slight weight gain
</em>
<em>B) change in the cervical mucus
</em>
<em>C) abdominal cramps
</em>
<em>D) fall in body temperature</em>
<u />
To learn more visit:
brainly.com/question/9864045?referrer=searchResults
A client is receiving somatropin. the nurse should monitor <u>Thyroid-stimulating hormone level </u>
<u />
- Somatropin injections are used to treat growth hormone insufficiency in both adults and children. Growth hormone is a natural hormone produced by your body.
- Children with specific diseases that hinder normal growth and development can potentially benefit from somatropin injections to accelerate their growth.
- The U.S. Food and Medicine Administration (FDA) has licensed the drug somatropin for a number of conditions, but it is mostly used to treat growth problems in children and growth hormone insufficiency in adults.
- For the purpose of treating HIV-related cachexia or wasting in patients with the virus, somatropin is FDA-approved under the trade name Serostim.
- Somatropin may be used off-label to treat the lipodystrophy syndrome linked to HIV.
learn more about Somatropin here: brainly.com/question/26390479
#SPJ4
The packaging of investigational drugs should ideally be designed to help with subject compliance.
<h3>What is investigational drugs?</h3>
Investigational drug is a substance that has been tested in the laboratory and has been approved by the U.S. Food and Drug Administration (FDA) for testing in people.
Investigational drug should be packaged to prevent contamination and unacceptable deterioration during transport and storage.
Thus, the packaging of investigational drugs should ideally be designed to help with subject compliance.
Learn more about investigational drugs here: brainly.com/question/1640938
#SPJ12
